This is an excellent and clear description of genetics vs genomics in the cancer world. “In this episode of the No One Missed: Biomarker Testing in MBC series, watch Jenny Burkholder, patient advocate and podcast host, discuss the concept of precision medicine with Dr. Mehta, MD, of MD Anderson Cancer Center, the essential differences between…
Rose Kushner a Maryland journalist and mother — was consistently certain her next article would be her breakthrough piece. She never dreamed it would be breast cancer that made her and her work known to the world. Author of seven books on the topic of breast cancer, Kushner’s work affected changes in laws and medical…
Join our fierce team of Drs. Ellen Landsberger and Jill Tirabassi, Victoria Goldberg, Judy Perkins, Lynda Weatherby, Martha Carlson, Ashley Fernandez, Alexis Desai, Melanie Sisk, Gwendolyn Boyce, and Abigail Johnston, Esq. as we share stories, insights, and expert guests, all while making this serious topic a bit more entertaining. Think of us as your co-stars…
Many patients are using large language models, or LLMs, like OpenAI’s ChatGPT, Anthropic’s Claude, and Google’s Gemini, to interpret their records. That help comes with some risk, though. Physicians and patient advocates warn that AI chatbots can produce wrong answers and that sensitive medical information might not remain private. Read more on NPR.
Cancer Research UK just shared its patient and public involvement toolkit Patient and public involvement (PPI) can improve the quality and relevance of your research, helping you better understand and articulate its benefits for cancer patients and members of the public.
Cancer care is changing — as are the clinical tools, tests and the terms used to diagnose and predict its path and treatment. Read more in this article from the Fred Hutch Cancer Center by ACE member Diana Mapes, featuring ACE member Ginny Mason.